CAS RN: 609-23-4
2,4,6-Triiodophenol
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250911
1g / 5g / 25g
Confirm by inquiry
Shanghai, Guangdong 5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 25g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 609-23-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
25g
≥97%
0
Out of Stock
Hong Kong
Inquiry
609-23-4 / 2,4,6-triiodophenol
Standard CAS: 609-23-4
Multi CAS: No
Basic Information
copy
CAS
609-23-4 copy
Multi CAS
No copy
Molecular Formula
C6H3I3O copy
Molecular Weight
471.800000 copy
Exact Mass
471.731800 copy
InChI
InChI=1S/C6H3I3O/c7-3-1-4(8)6(10)5(9)2-3/h1-2,10H copy
InChIKey
VAPDZNUFNKUROY-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Aromatic heavy atom count
6 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
66.26 copy
TPSA
20.23 copy
LogP / Solubility
WLOGP
3.21 copy
MLOGP
2.85 copy
XLogP3
3.5 copy
Consensus LogP
3.19 copy
Log S (ESOL)
-5.23 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-5.74 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-5.39 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-3.32 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy